A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Recovery Following Partial Medial Meniscectomy
Interventions
DRUG

Mesenchymal Stem Cells

DRUG

Hyaluronan

Trial Locations (8)

21218

Greater Chesapeake Associates, Baltimore

27704

Triangle Orthopaedics Associates, P.A., Durham

32960

Orthopedic Center of Vero Beach, Vero Beach

46237

Ortholndy, Indianapolis

55431

TRIA Orthopaedic Center, Bloomington

60612

Midwest Orthopaedics at Rush, Chicago

78233

Unlimited Research, San Antonio

90033

University of Southern California, Los Angeles

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Southern California

OTHER

collaborator

Midwest Orthopedics at Rush - Chicago, IL

UNKNOWN

collaborator

Unlimited Research - San Antonio, TX

UNKNOWN

collaborator

Triangle Orthopaedic Associates, P.A.

OTHER

collaborator

Orthopedic Center of Vero Beach - Vero Beach, FL

UNKNOWN

collaborator

OrthoIndy

OTHER

collaborator

TRIA Orthopaedic Center

OTHER

collaborator

Greater Chesapeake Orthopaedic Associates, LLC

OTHER

lead

Mesoblast International Sàrl

INDUSTRY

NCT00225095 - A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy | Biotech Hunter | Biotech Hunter